Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like What a Gilead-Incyte Marriage Would Look Like March 13, 2017 Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter And Connectivity Hub With Noninvasive Blood Pressure March 19, 2017 When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017
Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter And Connectivity Hub With Noninvasive Blood Pressure March 19, 2017
When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017
